Xlife Sciences strengthens sustainability activities with ESG strategy
Telefon: 0041 44 385 84 60
B?rsen: SIX Swiss Exchange??
About Xlife Sciences AG (SIX: XLS)
Xlife Sciences is a Swiss company focused as incubator and accelerator on the value development and commercialization of promising research projects from universities and other research institutions in the life sciences sector, with the aim of providing solutions for high unmet medical needs and a better quality of life. The goal is to bridge research and development to healthcare markets. Xlife Sciences takes carefully selected projects in the four areas of technological platforms, biotechnology/ therapies, medical technology, and artificial intelligence/digital health to the next stage of development, and participates in their subsequent performance. For more information, visit www.xlifesciences.ch
Some of the information contained in this media release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. Xlife Sciences undertakes no obligation to publicly update or revise any forward-looking statements.
End of Media ReleaseLanguage: English Company: Xlife Sciences AG Talacker 35 8001 Z?rich
Switzerland Phone: +41 44 385 84 60 E-mail: email@example.com Internet: www.xlifesciences.ch ISIN: CH0461929603 Valor: A2PK6Z Listed: SIX Swiss Exchange EQS News ID: 1446751 ? End of News EQS News Service